| Description |
1 online resource : illustrations (chiefly color) |
|
illustration |
| Contents |
Part 1. Introduction -- What Do We Consider Cancer of the Rectum? / Marilyne M. Lange and Cornelis J.H. van de Velde -- What Is the Ongoing Recommendation in the Management of Rectal Cancer? / Vincenzo Valentini, Hans-Joachim Schmoll and Cornelis J.H. van de Velde -- Part 2. Q & As on Risk Factor Identification -- What Prognostic Clinical Factors Must Be Considered Before Treatment? / Claus Rödel -- What Are the Relevant Imaging Factors to Optimize Treatment Decisions? / Manish Chand and Gina Brown -- What Biochemical and Molecular Biological Factors Have Greater Relevance to Treatment Decisions? / Guido Lammering and Jeroen Buijsen -- Do Different Populations of Rectal Cancer Exist? / Vincenzo Valentini, Francesco Cellini, Maria Cristina Barba and Ruud van Stiphout -- Part 3. Q & As on Imaging -- How Can We Identify Tumour Penetration? / Manish Chand and Gina Brown -- How Can We Identify Mesorectal Fascia Involvement? / Regina G.H. Beets-Tan -- How Can We Identify Nodal Involvement? / Regina G.H. Beets-Tan -- How Can We Identify Pathologic Complete Responders After Radiochemotherapy? / Brunella Barbaro and Lucia Leccisotti -- How Can We Identify Local Relapse? / Doenja M.J. Lambregts and Regina G.H. Beets-Tan -- Part 4. Q & As on Radiotherapy -- When Should Preoperative Short-Course Radiotherapy or Long-Course Chemoradiotherapy Be Performed? / David Sebag-Montefiore and Robert Glynne-Jones -- Should We Tailor the Delineation of Pelvic Structures According to Tumor Presentation? / Maria Antonietta Gambacorta and Vincenzo Valentini -- What Is the Role of IMRT and IGRT in Rectal Cancer? / Jasper Nijkamp, Karin Haustermans and Corrie A.M. Marijnen -- What Are the Dose-Volume Constraints to Reduce Late Toxicity? / Krzysztof Bujko -- What Is the Contribution of Intraoperative Radiotherapy (IORT) in Tailoring Local Therapy in Primary or Recurrent Rectal Cancer? / Felipe A. Calvo -- What Is the Contribution of Brachytherapy in Tailoring Local Therapy? / Jean-Pierre Gérard, Te Vuong, Jean-Michel Hannoun-Lévi and Arthur Sun Myint -- Part 5. Q & As on Chemotherapy -- Should Oxaliplatin Be Added to Preoperative Chemoradiation? / Carlo Aschele -- Should Biologic Targeted Agents Be Combined with Preoperative Chemoradiation in Rectal Cancer? / Pieter-Jan Cuyle and Eric Van Cutsem -- Should Upfront Chemotherapy Precede Preoperative Chemoradiation and Surgery? / Carlos Fernandez-Martos and Xabier Garcia de Albeniz -- How to Achieve Long-Term Survival in Patients with Metastatic Rectal Cancer? / Alexander Stein and Hans-Joachim Schmoll -- Will Adjuvant Chemotherapy Improve Outcome After Preoperative Chemoradiation? / Bengt Glimelius and Peter Nygren -- Part 6. Q & As on Surgery -- How to Evaluate the Quality of Surgery? Suggestions for Critical Reading of Surgical and Pathological Reports / Lars Påhlman -- How Is Nerve-Sparing Surgery Well Performed? / Zoran Krivokapic and Ivan Dimitrijevic -- Is Laparoscopic Rectal Surgery the Gold Standard? / David Jayne and Laeeq Khan -- Is a Diverting Stoma Always Necessary for a Low Anterior Resection of a Rectal Cancer? / Geerard L. Beets -- Will Extralevator Abdominoperineal Excision Become the New Gold Standard? / Ingrid Martijnse, Nicholas West, Phil Quirke, Richard Heald and Cornelius J.H. van de Velde, et al. -- Which Patients Do Benefit from Extended Resections in Case of Locally Advanced Rectal Cancer? / Ralph L. Dudink, Miranda Kusters and Harm Rutten -- Can Standard Surgical Procedure Reliably Be Avoided in Major Responders After Radio(chemo)therapy? / Claudio Coco and Gianluca Rizzo -- Part 7. Q & As on Pathology -- What Is the Correct Procedure for Handling the Surgical Specimen? / Nigel Scott -- What Is the Prognostic Value of (y)pT and (y)pN? / Nadine Ectors -- What Is the Prognostic Value of CRM Involvement? / Iris D. Nagtegaal -- What Is the Prognostic Value of TRG? / Fabio M. Vecchio -- Part 8. Q & As on Multidisciplinary Team Management -- What Are the Recommendations to Ensure a Successful Multidisciplinary Team in Rectal Cancer? / Sujay Shah, Pawan Mathur and Robert Glynne-Jones -- What Is the Appropriate Timetable for Tailored Follow-up? / Lars Påhlman -- How Should Data Be Shared and Rapid Learning Health Care Promoted? / Ruud van Stiphout, Erik Roelofs, Andre Dekker and Philippe Lambin |
| Summary |
This book seeks to promote an integrated approach among the various specialists involved in the management of rectal cancer with a view to ensuring that treatment is tailored appropriately to the individual patient. For ease of use, a question and answer format is employed. The focus is on those issues typically confronted during daily clinical practice in relation to risk factors, imaging, surgery, radiotherapy, and chemotherapy. The services of an outstanding panel of authors representative of the major European oncological societies have been acquired in order to formulate the questions and provide the answers. All who need assistance in addressing concerns that arise from the need for multidisciplinary management of rectal cancer will find the book to be an ideal source of helpful information |
| Analysis |
Medicine |
|
Radiology, Medical |
|
Radiotherapy |
|
Oncology |
|
Pathology |
|
Medicine & Public Health |
|
Surgical Oncology |
|
Diagnostic Radiology |
| Bibliography |
Includes bibliographical references and index |
| Subject |
Rectum -- Cancer -- Treatment
|
|
Rectum -- Cancer -- Surgery
|
|
Rectal Neoplasms -- therapy
|
|
Risk Factors
|
|
HEALTH & FITNESS -- Diseases -- Cancer.
|
|
MEDICAL -- Oncology.
|
|
Médecine.
|
|
Rectum -- Cancer -- Surgery
|
|
Rectum -- Cancer -- Treatment
|
| Form |
Electronic book
|
| Author |
Valentini, Vincenzo.
|
|
Schmoll, H.-J. (Hans-Joachim)
|
|
Velde, Cornelis J. H. van de.
|
| ISBN |
9783642250057 |
|
364225005X |
|
9786613845757 |
|
6613845752 |
|
9783642250040 |
|
3642250041 |
|
